Data / Form D filings / Antigenix Therapeutics, Inc.
Antigenix Therapeutics, Inc.: Form D filing
Antigenix Therapeutics, Inc., a health care company in Princeton, NJ, filed a Form D with the SEC in 2025. The latest, on October 24, 2025, reports $3.4 million sold of a $8.4 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 300 CARNEGIE CENTER, SUITE 150, Princeton, NJ, 08540
- Phone
- (317) 552-5240
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2073993
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 24, 2025 | New notice | $8,363,695 | $3,363,695 | $5,000,000 | 17 | Oct 22, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kwesi Frimpong-Boateng | Director | |
| Christopher Whitfield | Executive Officer, Director | |
| Shaun Hawkins | Director |
Other health care companies in New Jersey that filed recently
- SURGICAL CENTER OF SOUTH JERSEY LP $280,125 · Oct 8, 2026
- Morris County Surgical Center, LLC $140,380 · Sep 28, 2026
- Acuitive Technologies, Inc. $1.9 million · Sep 24, 2026
- Meca Industries Corp $37,500 · Sep 21, 2026
- ZT Technology PE 1, LLC offering · Sep 9, 2026
- OLI Technologies, Inc. offering · Sep 4, 2026
Every Form D from the week of Oct 20, 2025 · All recent filings in New Jersey · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Antigenix Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.